e-Drug3D

588

NAFTIFINE


INN
NAFTIFINE

cas 65472-88-0
CLASS

DERMATOLOGICALS
ANTIFUNGAL
ANTI-INFLAMMATORY

ROUTE (list)

TOPICAL

ATC code

D01AE22

PK parameters

Tmax 8 HOUR

Target

TARGET SQUALENE 2, 3-EPOXIDASE

DrugCentral

Squalene epoxidase UNIPROT Q4JEY0

Download SDF file N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine

Formula:
C21H21N

Calculated chemical properties:

MW 287.39
NB_atoms 22
XLogP 4.99
PSA 5.171
NB_HD 0
NB_HA 1
fsp3 0.14
Lipinski(0=no;1=yes) 1

FDA
NDA 019599 (label) INN (NAFTIFINE HYDROCHLORIDE) NAFTIN (LEGACY PHARMA) APPROVAL= AP YEAR= 1988
NDA 019356 (label) INN (NAFTIFINE HYDROCHLORIDE) NAFTIN (LEGACY PHARMA) APPROVAL= AP YEAR= 1990
NDA 204286 (label) INN (NAFTIFINE HYDROCHLORIDE) NAFTIN (LEGACY PHARMA) APPROVAL= AP YEAR= 2013
NDA 206901 (pdf not found) INN (NAFTIFINE HYDROCHLORIDE) NAFTIFINE HYDROCHLORIDE (TARO) APPROVAL= AP YEAR= 2016
NDA 205975 (pdf not found) INN (NAFTIFINE HYDROCHLORIDE) NAFTIFINE HYDROCHLORIDE (TARO) APPROVAL= AP YEAR= 2016
NDA 206960 (pdf not found) INN (NAFTIFINE HYDROCHLORIDE) NAFTIFINE HYDROCHLORIDE (AMNEAL) APPROVAL= AP YEAR= 2017
NDA 206165 (pdf not found) INN (NAFTIFINE HYDROCHLORIDE) NAFTIFINE HYDROCHLORIDE (AMNEAL) APPROVAL= AP YEAR= 2019
NDA 208201 (pdf not found) INN (NAFTIFINE HYDROCHLORIDE) NAFTIFINE HYDROCHLORIDE (TARO) APPROVAL= AP YEAR= 2019
NDA 210038 (pdf not found) INN (NAFTIFINE HYDROCHLORIDE) NAFTIFINE HYDROCHLORIDE (XIROMED) APPROVAL= AP YEAR= 2020

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL